Identification of key genes participating in copper-diethyldithiocarbamate-related cell death process and predicting the development of prostate cancer
Abstract Copper (Cu) is used as a cofactor in all organisms, and yet it can be toxic at high intracellular concentrations, causing cell death. Diethyldithiocarbamate (DDC) is a Cu ionophore that can transport Cu effectively into the cell. Copper-diethyldithiocarbamate (Cu-DDC) can treat prostate can...
Päätekijät: | Xin’an Wang, Chengdang Xu, Junjie Ma, Xiao Wang, Xi Chen |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
Springer
2024-10-01
|
Sarja: | Discover Oncology |
Aiheet: | |
Linkit: | https://doi.org/10.1007/s12672-024-01390-6 |
Samankaltaisia teoksia
-
Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent
Tekijä: Wehbe M, et al.
Julkaistu: (2017-05-01) -
Sodium diethyldithiocarbamate as accelerator of the rate of copper cementation
Tekijä: Abeer A. El-Saharty, et al.
Julkaistu: (2015-12-01) -
One-Step Synthesis of Nanoliposomal Copper Diethyldithiocarbamate and Its Assessment for Cancer Therapy
Tekijä: Radu A. Paun, et al.
Julkaistu: (2022-03-01) -
Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
Tekijä: Daciana C. Dumut, et al.
Julkaistu: (2025-02-01) -
Development of Liposomal Formulations of Zinc Diethyldithiocarbamate for Colorectal Cancer Treatment
Tekijä: Niusha Ansari-Fard, et al.
Julkaistu: (2022-11-01)